Treace(TMCI)

Search documents
Contact Levi & Korsinsky by June 10, 2025 Deadline to Join Class Action Against Treace Medical Concepts, Inc.(TMCI)
Prnewswire· 2025-05-02 09:45
NEW YORK, May 2, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Treace Medical Concepts, Inc. ("Treace Medical Concepts, Inc." or the "Company") (NASDAQ: TMCI) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Treace Medical Concepts, Inc. investors who were adversely affected by alleged securities fraud between May 8, 2023 and May 7, 2024. Follow the link below to get more information and be contacted by a member of our team:https://zl ...
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Treace Medical Concepts, Inc. (TMCI) Shareholders
GlobeNewswire News Room· 2025-05-01 16:49
NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Treace Medical Concepts, Inc. (NASDAQ: TMCI). Shareholders who purchased shares of TMCI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/treace-medical-concepts-inc-loss-submission-form-2/?id=146184&from=3 ...
Class Action Filed Against Treace Medical Concepts, Inc. (TMCI) - June 10, 2025 Deadline to Join - Contact The Gross Law Firm
Prnewswire· 2025-05-01 09:45
NEW YORK, May 1, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Treace Medical Concepts, Inc. (NASDAQ: TMCI).Shareholders who purchased shares of TMCI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/treace-medical-concepts-inc-loss-submission-form-2/?id=146172&from=4 CLASS PE ...
Treace Medical Concepts, Inc. (TMCI) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Prnewswire· 2025-04-30 16:00
Core Viewpoint - Investors in Treace Medical Concepts, Inc. have the opportunity to lead a securities fraud class action lawsuit due to undisclosed competitive impacts on the company's primary product and misleading statements from the defendants [1][2]. Summary by Relevant Sections Lawsuit Details - The lawsuit alleges that from May 8, 2023, to May 7, 2024, Treace Medical's defendants failed to disclose that competition affected the demand and utilization of the Lapiplasty 3D Bunion Correction System [2] - As a result of competitive pressures, Treace Medical's revenue declined, prompting the company to accelerate plans for an alternative product to osteotomy [2] - The defendants' positive statements regarding the company's business and prospects were materially misleading and lacked a reasonable basis during the relevant period [2] Participation Information - Investors who suffered losses in Treace Medical are encouraged to participate in the ongoing securities fraud lawsuit before the lead plaintiff deadline of June 10, 2025 [2] - Interested parties can contact the Law Offices of Frank R. Cruz for more information on participation [3][4]
Contact Levi & Korsinsky by June 10, 2025 Deadline to Join Class Action Against Treace Medical Concepts, Inc. (TMCI)
GlobeNewswire News Room· 2025-04-29 17:10
NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Treace Medical Concepts, Inc. ("Treace Medical Concepts, Inc." or the "Company") (NASDAQ: TMCI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Treace Medical Concepts, Inc. investors who were adversely affected by alleged securities fraud between May 8, 2023 and May 7, 2024. Follow the link below to get more information and be contacted by a member of our team: h ...
Levi & Korsinsky Reminds Treace Medical Concepts, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 10, 2025 - TMCI
Prnewswire· 2025-04-29 09:45
Core Viewpoint - A class action securities lawsuit has been filed against Treace Medical Concepts, Inc. due to alleged securities fraud impacting investors between May 8, 2023, and May 7, 2024 [1] Group 1: Allegations and Impact - The lawsuit claims that Treace Medical Concepts concealed the impact of competition on the demand for its primary product, the 3D bunion correction system known as "Lapiplasty" [2] - As a result of competitive pressures, Treace Medical's revenue declined, prompting the company to accelerate plans for an alternative product to osteotomy [2] - Defendants allegedly made materially misleading statements regarding the company's business operations and future prospects [2] Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until June 10, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this role [3] - Class members may be entitled to compensation without incurring any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky has a history of securing significant settlements for shareholders and is recognized as one of the top securities litigation firms in the United States [4]
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of June 10, 2025 in Treace Medical Concepts, Inc. Lawsuit – TMCI
GlobeNewswire News Room· 2025-04-28 16:33
Core Viewpoint - Treace Medical Concepts, Inc. (NASDAQ: TMCI) is facing a class action lawsuit due to allegations of issuing materially false and misleading statements regarding its primary product, the 3D bunion correction system, "Lapiplasty" [3]. Summary by Relevant Sections Class Period and Allegations - The class period for the lawsuit is from May 8, 2023, to May 7, 2024 [3]. - Allegations include that competition negatively impacted the demand for the Lapiplasty system, leading to a decline in Treace Medical's revenue [3]. - The company needed to accelerate plans for an alternative product to osteotomy due to these challenges [3]. - Defendants' positive statements about the company's business and prospects were claimed to be materially misleading [3]. Next Steps for Shareholders - Shareholders who purchased TMCI shares during the specified period are encouraged to register for the class action by June 10, 2025 [4]. - Registration allows shareholders to receive updates through portfolio monitoring software [4]. - Participation in the case incurs no cost or obligation for shareholders [4]. Law Firm Information - The Gross Law Firm is leading the class action and is recognized for protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements [5].
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Treace Medical
GlobeNewswire News Room· 2025-04-26 14:56
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Treace Medical To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Treace Medical between May 8, 2023, and May 7, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, April 26, 2025 (GLOBE NEWSWIRE) -- ...
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TMCI
GlobeNewswire News Room· 2025-04-26 13:33
Group 1 - The Rosen Law Firm is reminding purchasers of Treace Medical Concepts, Inc. securities of the June 10, 2025 lead plaintiff deadline for a class action lawsuit [1] - Investors who purchased Treace Medical securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties can join by contacting the Rosen Law Firm [3][6] Group 2 - The lawsuit alleges that during the Class Period, Treace Medical made false or misleading statements regarding competition affecting the demand for its primary product, the Lapiplasty 3D Bunion Correction System [5] - It is claimed that Treace Medical's revenue declined, necessitating an acceleration of plans to offer an alternative product to osteotomy [5] - The lawsuit asserts that the positive statements made by Treace Medical about its business and prospects were materially misleading and lacked a reasonable basis [5] Group 3 - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4] - The firm has achieved significant settlements for investors, including over $438 million in 2019 and has been ranked highly in securities class action settlements since 2013 [4]
TMCI Investors Have Opportunity to Lead Treace Medical Concepts, Inc. Securities Fraud Lawsuit
Prnewswire· 2025-04-26 12:45
Group 1 - The Rosen Law Firm is reminding purchasers of Treace Medical Concepts, Inc. securities from May 8, 2023, to May 7, 2024, about the June 10, 2025, lead plaintiff deadline for a class action lawsuit [1] - Investors who purchased Treace Medical securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by June 10, 2025 [3] Group 2 - The lawsuit alleges that during the class period, Treace Medical made false or misleading statements regarding competition affecting the demand for its primary product, the Lapiplasty 3D Bunion Correction System, leading to a decline in revenue [5] - The lawsuit claims that Treace Medical needed to accelerate plans for an alternative product to osteotomy due to the impact of competition [5] - Defendants' positive statements about Treace Medical's business and prospects were materially misleading and lacked a reasonable basis, resulting in investor damages when the truth was revealed [5] Group 3 - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in recovering significant amounts for investors [4] - The firm has been recognized for its performance in securities class action settlements, including a record settlement against a Chinese company and ranking highly in the number of settlements achieved [4]